blog

European stocks mixed; strong AstraZeneca numbers help U.K. outperform

AstraZeneca stock rose 3.5% after the drugmaker delivered better-than-expected profits and sales in the second quarter as a strong performance of its blockbuster cancer drugs helped offset the loss of COVID-19 vaccine sales.

All comments


Comment not found